Illustration of a futuristic life science research campus under reconstruction, with cranes and glowing laboratory buildings, symbolizing Alexandria Real Estate’s turnaround in biotech real estate.

Alexandria Real Estate (ARE): The Life Science “Dr. Frankenstein” Pivot — Rebuilding the Lab from the Floor Up

Alexandria Real Estate (ARE) is the king of life science labs—and one of the most punished REITs of the last five years. After a brutal dividend cut, asset write-downs, and a 75% drawdown, the founder just bought $1.3M of stock and the company is buying back shares. Is this a broken experiment—or a classic cycle-bottom setup?

 

Read entire article

Cartoon-style digital illustration of a Bunge-branded tractor harvesting moneybags from a golden cornfield labeled “Dividends,” while institutional investors in suits chase behind with pitchforks and a banner reading “Merger, Anyone?”

Bunge: Time for the Big Binge?

🛢️ Agribusiness giant Bunge is getting squeezed—but don’t count it out yet. With a massive merger on deck, insider and institutional support strong, and shares trading at low multiples, could it be time for a contrarian feast?

Read entire article